risks of glp 1 inhibitors Adverse Effects GLP-1 Receptor Agonists For patients taking GLP-1 receptor

[Internet] [DOI] [PMC free article] [PubMed] [Google Scholar] Ng M, Gakidou E, Lo J, Abate YH, Abbafati C, Abbas N, Abbasian M

If elevated risk is present, discontinuation should be considered, weighing risks of metabolic decompensation

We found that theres a need to offer patients high-protein options to maintain critically important lean muscle mass and stave off nausea, as well as products fortified with micronutrients, like vitamins and minerals, to mitigate against dietary deficits

A mean reduction in body weight of 7% in participants following a low-energy diet resulted in significantly more patients responding (according to reduction in PASI score) to low-dose ciclosporin [17]

For type 2 diabetes , NICE recommends GLP-1 receptor agonists as second- or third-line therapy when metformin and other oral agents have not achieved adequate glycaemic control, or as an alternative to insulin in certain circumstances

When possible, schedule outings during slow periods to minimize contact with others